DE60115237D1 - Praziquantel zusammensetzungen zur behandlung von krankheiten verursacht durch kokzidien - Google Patents

Praziquantel zusammensetzungen zur behandlung von krankheiten verursacht durch kokzidien

Info

Publication number
DE60115237D1
DE60115237D1 DE60115237T DE60115237T DE60115237D1 DE 60115237 D1 DE60115237 D1 DE 60115237D1 DE 60115237 T DE60115237 T DE 60115237T DE 60115237 T DE60115237 T DE 60115237T DE 60115237 D1 DE60115237 D1 DE 60115237D1
Authority
DE
Germany
Prior art keywords
praziquantel
compositions
cozzidia
treatment
diseases caused
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60115237T
Other languages
English (en)
Other versions
DE60115237T2 (de
Inventor
J Kennedy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Bayer Corp
Original Assignee
Bayer AG
Bayer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG, Bayer Corp filed Critical Bayer AG
Application granted granted Critical
Publication of DE60115237D1 publication Critical patent/DE60115237D1/de
Publication of DE60115237T2 publication Critical patent/DE60115237T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06Antiabortive agents; Labour repressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Anesthesiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE60115237T 2000-05-23 2001-05-18 Praziquantel zusammensetzungen zur behandlung von krankheiten verursacht durch kokzidien Expired - Lifetime DE60115237T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US576791 2000-05-23
US09/576,791 US6429211B1 (en) 2000-05-23 2000-05-23 Praziquantel compounds for treating diseases due to Sarcocystis Neospora Toxoplasma and Isospora
PCT/US2001/016440 WO2001089497A2 (en) 2000-05-23 2001-05-18 Praziquantel compositions for treating diseases due to sarcocystis, neospora, toxoplasma and isospora

Publications (2)

Publication Number Publication Date
DE60115237D1 true DE60115237D1 (de) 2005-12-29
DE60115237T2 DE60115237T2 (de) 2006-06-29

Family

ID=24306001

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60115237T Expired - Lifetime DE60115237T2 (de) 2000-05-23 2001-05-18 Praziquantel zusammensetzungen zur behandlung von krankheiten verursacht durch kokzidien

Country Status (19)

Country Link
US (2) US6429211B1 (de)
EP (1) EP1296686B1 (de)
JP (1) JP4991076B2 (de)
KR (1) KR100821112B1 (de)
CN (1) CN1250222C (de)
AT (1) ATE310521T1 (de)
AU (1) AU2001274886A1 (de)
BR (1) BR0111014A (de)
CA (1) CA2409926C (de)
DE (1) DE60115237T2 (de)
DK (1) DK1296686T3 (de)
ES (1) ES2252242T3 (de)
HK (1) HK1059894A1 (de)
HU (1) HUP0302330A3 (de)
MX (1) MXPA02011453A (de)
NZ (1) NZ522687A (de)
PL (1) PL202041B1 (de)
WO (1) WO2001089497A2 (de)
ZA (1) ZA200208770B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006061214A1 (en) * 2004-12-10 2006-06-15 Bayer Healthcare Ag Anthelmintic composition
US8563554B2 (en) 2009-03-17 2013-10-22 Concert Pharmaceuticals, Inc. Deuterated pyrazinoisoquinoline compounds
CA3033065A1 (en) 2016-08-11 2018-02-15 Adamis Pharmaceuticals Corporation Drug compositions
US11564910B2 (en) 2017-12-08 2023-01-31 Adamis Pharmaceuticals Corporation Drug compositions
WO2020093014A1 (en) * 2018-11-02 2020-05-07 Adamis Pharmaceuticals Corporation Drug compositions

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2362539C2 (de) 1973-12-17 1986-05-07 Merck Patent Gmbh, 6100 Darmstadt 2-Acyl-4-oxo-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isochinoline, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US4447414A (en) 1982-12-21 1984-05-08 Cutter Laboratories, Inc. Carnivore anthelmintics
DE3634755A1 (de) * 1986-10-11 1988-04-14 Bayer Ag Dermale behandlung von wurmerkrankungen der katze mit praziquantel
DE3805660A1 (de) 1988-02-24 1989-09-07 Bayer Ag Substituierte 1,2,4-triazindione, verfahren zu ihrer herstellung und ihre verwendung
DE3826058A1 (de) 1988-07-30 1990-02-08 Bayer Ag Mittel gegen fischparasiten
US4933341A (en) 1988-10-08 1990-06-12 Bayer Aktiengesellschaft Substituted 1,3,5-triazinetriones, for use against parasitic protozoa
US5196562A (en) 1988-10-08 1993-03-23 Bayer Aktiengesellschaft Substituted 1,3,5-triazinetriones, for use against parasitic protozoa
EP0377903A3 (de) 1989-01-09 1991-07-17 Bayer Ag Substituierte Hexahydro-1,2,4-triazindione, Verfahren zu ihrer Herstellung, Zwischenprodukte dafür und ihre Verwendung
CN1044905A (zh) 1989-02-16 1990-08-29 赫彻斯特股份公司 鱼和昆虫寄生虫对抗剂
DE4030042A1 (de) 1990-05-17 1991-11-21 Bayer Ag Verwendung von substituierten 1,2,4-triazindionen
DE4120138A1 (de) 1991-06-19 1992-12-24 Bayer Ag Substituierte hexahydro-1,2,4-triazindione, verfahren zu ihrer herstellung, zwischenprodukte dafuer und ihre verwendung
AUPM969994A0 (en) 1994-11-28 1994-12-22 Virbac S.A. Equine anthelmintic formulations
US5663155A (en) 1994-11-30 1997-09-02 The University Hospital Compositions for the treatment of parasitic infections
JPH0987196A (ja) * 1995-09-25 1997-03-31 Masatoshi Nakano 寄生虫駆除・駆虫剤
US6051604A (en) * 1995-12-07 2000-04-18 The Proctor & Gamble Company Methods and compositions for the prevention and treatment of gastrointestinal disorders
US6180604B1 (en) * 1996-08-21 2001-01-30 Micrologix Biotech Inc. Compositions and methods for treating infections using analogues of indolicidin
WO2000078149A1 (en) * 1999-06-18 2000-12-28 Bayer Aktiengesellschaft Anthelmintic compositions

Also Published As

Publication number Publication date
JP4991076B2 (ja) 2012-08-01
BR0111014A (pt) 2003-04-08
CN1250222C (zh) 2006-04-12
ZA200208770B (en) 2003-10-30
DK1296686T3 (da) 2006-04-03
WO2001089497A3 (en) 2002-11-28
AU2001274886A1 (en) 2001-12-03
US6429211B1 (en) 2002-08-06
CN1452489A (zh) 2003-10-29
HUP0302330A2 (hu) 2003-11-28
KR20020097257A (ko) 2002-12-31
DE60115237T2 (de) 2006-06-29
EP1296686A2 (de) 2003-04-02
JP2003534275A (ja) 2003-11-18
US20020143018A1 (en) 2002-10-03
ES2252242T3 (es) 2006-05-16
KR100821112B1 (ko) 2008-04-11
HUP0302330A3 (en) 2012-02-28
WO2001089497A2 (en) 2001-11-29
PL202041B1 (pl) 2009-05-29
MXPA02011453A (es) 2003-05-23
EP1296686B1 (de) 2005-11-23
HK1059894A1 (en) 2004-07-23
NZ522687A (en) 2004-07-30
CA2409926A1 (en) 2001-11-29
CA2409926C (en) 2009-11-03
PL360503A1 (en) 2004-09-06
ATE310521T1 (de) 2005-12-15

Similar Documents

Publication Publication Date Title
ATE512976T1 (de) Hemmer des hepatitis-c-virus
ATE309999T1 (de) Blutplättchen-adp-rezeptor-inhibitoren
EA200400162A1 (ru) N-(3-амино-2-гидроксипропил)замещенные алкиламидные соединения
EA200500723A1 (ru) Соединения бензофурана, композиции и способы лечения и профилактики инфекций, вызванных вирусом гепатита c, и связанных с ним заболеваний
EA200300318A1 (ru) Пептидомиметические ингибиторы протеазы
EA200800413A1 (ru) Новые макроциклические ингибиторы репликации вируса гепатита с
CO4410317A1 (es) Combinacion y conjuntos farmaceuticos de un antagonista o- pioide y un inhibidor de recaptacion selectiva de serotoni- na, y el tratamiento de alcoholismo y dependencia alcoholica empleando los mismos.
LV12291A (lv) Savienojums un farmaceitiskas kompozicijas ar triptazes aktivitates izmainam saistitu slimibu arstesanai
EA200001085A1 (ru) 5-аминоиндено [1, 2-с]пиразол-4-оны в качестве противораковых и антипролиферативных агентов
ATE457177T1 (de) Kombinationstherapie zur behandlung respiratorischer krankheiten mittels antikörper und anti-entzündungs wirkstoffe
BR0004538A (pt) Combinação eficaz para o tratamento da impotência
DE69918716D1 (de) Triazinoneverbindungen für die behhandlung von krankheiten verursacht durch neospora und toxoplasma
EA200200995A1 (ru) Применение композиций азалидных антибиотиков для лечения или предупреждения бактериальных или протозойных инфекций у млекопитающих
DE60115237D1 (de) Praziquantel zusammensetzungen zur behandlung von krankheiten verursacht durch kokzidien
ATE302011T1 (de) PONAZURIL ZUR BEHANDLUNG VON DURCH COCCIDIA NEUROLOGISCHEN UND ßABORTIGENICß VERURSACHTEN ERKRANKUNGEN
ATE320797T1 (de) Verwendung von 6-dimethylaminomethyl-1-phenyl- cyclohexanverbindungen zur therapie der harninkontinenz
EA200500398A1 (ru) ПРОЛЕКАРСТВО ИНГИБИТОРА β-ЛАКТАМАЗЫ
DE69817381D1 (de) Zusammensetzung und diese enthaltende pharmazeutische zubereitung für die behandlung von herpes und verwandten viralen infektionen
EA200200846A1 (ru) Соединения, полезные для лечения или предупреждения заболеваний, опосредуемых альфа-2в-адреноцептором
LV12459A (lv) Savienojums un farmaceitiskas kompozicijas ar triptazes aktivitates izmainam saistitu slimibu arstesanai

Legal Events

Date Code Title Description
8364 No opposition during term of opposition